Clinical Trial Detail

NCT ID NCT00549848
Title Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements no
Sponsors St. Jude Children's Research Hospital
Indications

acute lymphocytic leukemia

Therapies

Vincristine + Pegaspargase + Daunorubicin

Cytarabine

Mercaptopurine

Thioguanine

Clofarabine + Etoposide + Cyclophosphamide

Methotrexate

Dasatinib

Doxorubicin

Dexamethasone

Age Groups: child

No variant requirements are available.